• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy

tetano

Editor, Senior Moderator
Vaccines (Basel). 2018 May 25;6(2). pii: E31. doi: 10.3390/vaccines6020031.
[h=1]Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.[/h] Gallagher JR[SUP]1[/SUP], McCraw DM[SUP]2[/SUP], Torian U[SUP]3[/SUP], Gulati NM[SUP]4[/SUP], Myers ML[SUP]5[/SUP], Conlon MT[SUP]6[/SUP], Harris AK[SUP]7[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza viruses affect millions of people worldwide on an annual basis. Although vaccines are available, influenza still causes significant human mortality and morbidity. Vaccines target the major influenza surface glycoprotein hemagglutinin (HA). However, circulating HA subtypes undergo continual variation in their dominant epitopes, requiring vaccines to be updated annually. A goal of next-generation influenza vaccine research is to produce broader protective immunity against the different types, subtypes, and strains of influenza viruses. One emerging strategy is to focus the immune response away from variable epitopes, and instead target the conserved stem region of HA. To increase the display and immunogenicity of the HA stem, nanoparticles are being developed to display epitopes in a controlled spatial arrangement to improve immunogenicity and elicit protective immune responses. Engineering of these nanoparticles requires structure-guided design to optimize the fidelity and valency of antigen presentation. Here, we review electron microscopy applied to study the 3D structures of influenza viruses and different vaccine antigens. Structure-guided information from electron microscopy should be integrated into pipelines for the development of both more efficacious seasonal and universal influenza vaccine antigens. The lessons learned from influenza vaccine electron microscopic research could aid in the development of novel vaccines for other pathogens.


[h=4]KEYWORDS:[/h] cryo-EM; design; electron microscopy; influenza; structure; vaccines

PMID: 29799445 DOI: 10.3390/vaccines6020031
 
Back
Top Bottom